secwatch.observer — SEC 8-K summary
======================================

Issuer:     TREACE MEDICAL CONCEPTS, INC. (TMCI)
CIK:        0001630627
Form:       8-K
Filed at:   2022-09-28T23:59:59+00:00
Accession:  0000950170-22-018920
Event type: leadership
Sentiment:  neutral
Materiality: 0.45
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Treace Medical appoints Lance Berry and Jane Kiernan to board effective Oct 1, 2022
--------------------------------------------------------------------------------

- Appointed Lance A. Berry (former Wright Medical CFO) and Jane E. Kiernan (CEO of Surgimatix) to board, effective Oct 1, 2022.
- Berry will serve on Audit Committee; Kiernan on Compensation Committee.
- Both qualify as independent directors under Nasdaq rules.
- Berry brings ~20 years of medical device financial leadership; Kiernan has 30+ years of healthcare executive experience.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1630627/000095017022018920/0000950170-22-018920-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1630627/000095017022018920/tmci-20220927.htm
  HTML page:      https://secwatch.observer/filing/0000950170-22-018920

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer